FR's strong earnings, resilient financials, and 3.5% yield make it a top choice for long-term investors amid market ...

Discover why STMicroelectronics N.V. faces challenges like tariff risks, margin pressures, and soft U.S. auto demand. Click for my updated look at STM stock.

Sarepta stock tanked Friday after a new patient death was uncovered, spurring an FDA request to halt shipments of an ...

Eternal's quick commerce now makes for almost half of the company's $10 billion annualized net order value, signaling a major ...

It feels as if every quarterly earnings report is a big deal for Tesla. And, yes, the coming second-quarter report, due Wednesday, is important for the electric-vehicle maker.A lot has happened.

Benchmark analyst Mickey Legg initiated coverage of shares of the auto maker with a Buy rating and $65 price target.

Keytruda was first approved in Canada in 2015 and is approved for the treatment of several cancers affecting the bladder, lung, breast, head and neck, and other areas.